Standalone Havas inches ahead as Pfizer loss hits US
Havas is claiming “record results” in its first year of trading as a separate entity but, in truth, net revenue inching forward 1.5% to €2,736m is hardly spectacular. Organic growth for the year fell by 0.8%, hammered (as were most of its rivals apart from Publicis) by a flat Q4. Small, bolt-on acquisitions accounted for … The post Standalone Havas inches ahead as Pfizer loss hits US first appeared on More About Advertising.

Havas is claiming “record results” in its first year of trading as a separate entity but, in truth, net revenue inching forward 1.5% to €2,736m is hardly spectacular. Organic growth for the year fell by 0.8%, hammered (as were most of its rivals apart from Publicis) by a flat Q4. Small, bolt-on acquisitions accounted for …
The post Standalone Havas inches ahead as Pfizer loss hits US first appeared on More About Advertising.